Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Thomas Littke"'
Autor:
Giancarlo Viberti, Johannes F.E. Mann, Susan Kuranoff, Damian Green, Kenneth Jamerson, Luis M. Ruilope, Thomas Littke
In the short term, the endothelin antagonist avosentan reduces proteinuria, but whether this translates to protection from progressive loss of renal function is unknown. We examined the effects of avosentan on progression of overt diabetic nephropath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ae5dac3defc0756ed8592d322fb8c0
https://europepmc.org/articles/PMC2831858/
https://europepmc.org/articles/PMC2831858/
Autor:
Susan Kuranoff, René R. Wenzel, Thomas Philipp, Eberhard Ritz, Heike Bruck, Anna Mitchell, Christiane Jürgens, Thomas Littke
Despite the first-line use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), there is still a large need to improve the prevention and progression of diabetic nephropathy and its associated cardiovascular e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a86ff9249eabc309de180d333fc8fe
https://europepmc.org/articles/PMC2653691/
https://europepmc.org/articles/PMC2653691/